ClinicalTrials.Veeva

Menu

Personalised Prediction of Disease Course in Ulcerative Colitis Using Multimodal Machine Learning - Part of the Presager Project (Presager II)

C

Copenhagen University Hospital, Hvidovre

Status

Enrolling

Conditions

Ulcerative Colitis

Treatments

Other: Deep learning model

Study type

Observational

Funder types

Other

Identifiers

NCT05479617
H-21020965

Details and patient eligibility

About

In patients achieving clinical remission following a flare, artificial intelligence can reliably predict a new flare within the next 12 months utilizing clinical and objective information at day 0 and week 8.

Secondary endpoints:

  • An artificial intelligence model's precision in predicting a new flare within 2 and 3 years
  • An artificial intelligence model's precision to rule out patients who will not experience a new flare within 1, 2 and 3 year

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

  • Signed informed consent
  • Diagnosis of UC for at least 1 year
  • Relapse due to UC.
  • First endoscopic and histological evaluation of the flare Exclusion criteria
  • Well-founded doubt that the flare is due to other than the patients UC

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems